Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bivalirudin versus heparin during PCI after thrombolysis in STEMI
ChiCTR2000035602Phase 4Not yet recruiting
- Sponsor
- Tangdu Hospital
- Start
- Oct 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in myocardial infarction (MI) comparing Bivalirudin group with Heparin group (2 arms). Primary endpoint: 30-day all-cause death or BARC 3-5 bleeding. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
bivalirudinheparin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2000035602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035602.